Nalon-Ace® and other nonsteroidal anti-inflammatory drugs (NSAID) containing bromvalerylurea (BVU) are sold as over-the-counter (OTC) drugs and are obtainable without prescription in Japan. A 32-year-old womanwas diagnosed as having chronic BVUintoxication due to habitual use ofNalon-Ace®. In addition to cerebellar ataxia and pyramidal signs well known in this condition, she showedan as yet non-described dystonic posture of the neck. Laboratory tests revealed an elevated concentration of serum organic bromide, iron deficiency anemia, and hyperchloremia. Brain magnetic resonance imaging (MRI) revealed definite cerebellar atrophy.
Introduction
Bromvalerylurea (BVU= bromisovalum) is a kind of organic bromide belonging to the monoureide family. Inorganic and organic bromides, the latter being practically only BVUin medicine ( 1 , 2) , are known to cause acute and chronic intoxication. Respective poisoning symptomsdue to these two compounds are said to differ in frequency and severity (3, 4) . BVUper se used to be widely used to treat insomnia and for sedation, but it is likely that its consumption in the world is tending to decrease because of the acute and chronic intoxication (5). Nevertheless, since nonsteroidal anti-inflammatory drugs (NSAID) containing B VUare available without prescription in Japan, westill occasionally encounter cases of chronic intoxication by BVUincluded in such NSAID (1, 5-1 1) . Acute BVUintoxication is usually associated with suicide attempts, and includes consciousness disturbance and respiratory failure ( 1 2). Meanwhile, chronic BVUintoxication, which is usually due to its abuse, involves various neurological symptoms and signs including tremor, cerebellar ataxia, pyramidal signs, ophthalmoplegia, peripheral neuropathy and autonomic dysfunction (1 1, 12) .
Werecently encountered a patient with chronic BVUintoxication presenting cerebellar ataxia, pyramidal signs and a dystonic posture of the neck. To our knowledge, this is the first case of chronic BVUintoxication showing a dystonic posture.
In this report we emphasize that weshould be aware of chronic BVUintoxication in cases of NSAIDabuse which exhibit neurological features, as in our case.
Case Report
A 32-year-old housewife was admitted to our hospital because of gait disturbance at the beginning of October, 1996. After she had a fever of 38°C at the beginning of September 1 996, she noticed tremor of the upper and lower extremities and the neck, gait disturbance, dysarthria, and nuchal myalgia.
Neurological examination on the first admis sion revealed slurred speech, tremor of all the extremities, an ataxic gait, truncal titubation, diffuse hyperreflexia, bilateral ankle clonus, spasticity of the lower extremities, and bilateral Babinski signs. She had no history of alcohol abuse. We diagnosed her as having viral cerebellitis at that time. Since her symptoms had gradually improved within a month without any treatment, we decided to Bromvalerylurea Poisoning follow her at our out-patient department.
After discharge, her gait disturbance gradually worsened again and she began to experience back myalgia. She was readmitted to our hospital in March 1 997, when we became aware of her Nalon-Ace® abuse for the first time. She had experienced chronic and intractable headaches at age 14, but never had received prescribed drugs including flunaridine. She had tried many over-the-counter (OTC) drugs on her own. At age 26 she noticed that Nalon-Ace® relieved her habitual headache, and she used to take about 24 tablets of the drug (2,400 mg of BVU)each month. When she was 28 years old (1992), she was taking about 48 tablets of the same drug a month (4,800 mg of BVU). Neurological re-examination in March 1 997, revealed a dystonic posture of the neck (she protruded her head anteriorly) in addition to slurred and explosive speech, limb and truncal ataxia, tremor, hyperreflexia, ankle clonus, spasticity of the lower extremities, and a Babinski sign on the right side.
Laboratory tests on the second admission revealed iron deficiency anemia with low hemoglobin (10.8 g/dl) and serum iron (27 jug/dl; normal, 70-1 30) levels, and elevation ofunsatu- (Fig. 1) . Discontinuance of Nalon-Ace® led to improvement of the spasticity of the lower extremities and the ataxic gait (Fig. 2) .
Discussion
The diagnosis of this case was chronic BVUintoxication, based on the following findings: 1) a distinct history of abuse of Nalon-Ace®, which contains BVU, 2) elevated serum BVU concentrations, 3) relief of symptomsafter cessation of NalonAce®ingestion, 4) worsened symptoms on its retrial, and 5) pseudo-hyperchloremia. Although chronic BVUintoxication usually becomes apparent at a serum BVUlevel of 50-80 mg/ dl (1, 5) , the present case developed neurological symptoms with relatively low serum concentrations of BVU(16-26 mg/ dl). This might be due to different individual sensitivities to BVU.
The clinical features of chronic BVUintoxication comprise various combinations of ocular symptoms, pyramidal signs, tremor, ataxia, and autonomic nervous dysfunction (13). In particular, cerebellar ataxia is a commonclinical feature of the intoxication (3, 4). Since previous reports on this condition did not mention dystonia, the dystonic posture of the neck in our patient is noteworthy. This finding suggests that BVUaffects not only the cerebellar but also the extrapyramidal system. Brain MRIin our case revealed cerebellar atrophy, which was intensified in the upper portions of the vermis and hemispheres, which resembles that in several cases of chronic BVU intoxication (9, 1 1 , 1 4). Miyama reported that cerebellar Purkinje cells were lost in such cases (7). Since this pattern of cerebellar atrophy in chronic BVUintoxication resembles those in chronic alcoholism and phenytoin intoxication (9), the mechanism underlying the cerebellar atrophy might be commonin these conditions.
The non-neurologic manifestations of chronic BVUintoxication include skin lesions like acneiform eruptions, anemia, and body weight loss due to unknown mechanisms (2, 4, 12, 1 3). Weobserved iron deficiency anemia in this case too, but it remains undetermined whether or not iron deficiency is a commonmechanism of anemia seen in BVUintoxication; Arai et al reported anemia possibly due to folic acid deficiency in a case of BVUintoxication (ll). The present case exhibited microcytic and hypochromic anemia, and normal folic acid and vitamin B12 levels, which thus probably rules out folic acid deficiency as the cause of the anemia. Apparent hyperchloremia is usually noted in BVUpoisoning because bromides cannot be distinguished from chlorides, and are quantitated as chlorides with conventional measurement methods (2). In our case, the presence of pseudohyperchloremia was a key to the accurate diagnosis ofBVUpoisoning, as in some previous reports (2, 8, 15 ).
Although there have been manycase reports of acute BVU intoxication due to its use in suicide attempts in Japan, our intensive literature search revealed only 12 cases of chronic BVUintoxication (5-1 1 , 15). However, chronic BVUintoxication is speculated to occur more frequently because many people are likely to habitually use OTCNSAIDincluding BVUin Japan. In cases showing cerebellar ataxia, pyramidal signs and a dystonic posture, weshould be aware of chronic BVUintoxication and should check the history of such NSAID abuse. Furthermore, weshould recognize that there are a number of other drugs that contain BVUand thus can cause such intoxication (2). Moreover, it may be necessary to advise patients on the proper usage of OTCdrugs.
